Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
3rd Aug 2015 3:00 pm RNS Total Voting Rights
30th Jul 2015 7:01 am RNS Half Yearly Report
29th Jul 2015 9:00 am RNS Notice of Results
27th Jul 2015 11:00 am RNS Confirmation of Change in ADS Ratio
27th Jul 2015 7:00 am RNS AstraZeneca agreement with Genzyme on Caprelsa
22nd Jul 2015 7:00 am RNS AstraZeneca commences Phase II Trial
17th Jul 2015 11:00 am RNS Holding(s) in Company
17th Jul 2015 7:05 am RNS AZ completes agreement with Tillotts for Entocort
14th Jul 2015 7:00 am RNS IRESSA approved by US FDA
9th Jul 2015 7:32 am RNS Agreement with Tillotts on Entocort
1st Jul 2015 11:00 am RNS Total Voting Rights
26th Jun 2015 12:00 pm RNS Change in ADS ratio
25th Jun 2015 11:30 am RNS Publication of Prospectus
16th Jun 2015 2:00 pm RNS Director/PDMR Shareholding
3rd Jun 2015 3:00 pm RNS Holding(s) in Company
1st Jun 2015 3:00 pm RNS Total Voting Rights
1st Jun 2015 3:00 pm RNS AstraZeneca PLC - Blocklisting Interim Review
26th May 2015 7:01 am RNS UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME
18th May 2015 10:07 am RNS AstraZeneca to invest £182m to expand drug plant in Sweden
13th May 2015 3:00 pm RNS Holding(s) in Company
8th May 2015 2:00 pm RNS Director/PDMR Shareholding
8th May 2015 11:00 am RNS Director/PDMR Shareholding - Replacement
8th May 2015 10:00 am RNS Director/PDMR Shareholding
7th May 2015 2:00 pm RNS Director Declaration
1st May 2015 4:00 pm RNS Director/PDMR Shareholding
1st May 2015 11:00 am RNS Total Voting Rights
29th Apr 2015 5:30 pm RNS Director/PDMR Shareholding
24th Apr 2015 5:30 pm RNS Result of AGM
24th Apr 2015 7:02 am RNS 1st Quarter Results
24th Apr 2015 7:01 am RNS Collaboration with Celgene on PD-L1 in haematology
24th Apr 2015 7:00 am RNS AZ and Innate to collaborate in immuno-oncology
23rd Apr 2015 9:00 am RNS Notice of Results
17th Apr 2015 7:00 am RNS Selumetinib granted Orphan Drug Designation by FDA
15th Apr 2015 7:02 am RNS Tremelimumab granted Orphan Drug Designation
15th Apr 2015 7:00 am RNS FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS
1st Apr 2015 11:00 am RNS Total Voting Rights
30th Mar 2015 3:00 pm RNS Director/PDMR Shareholding
19th Mar 2015 11:00 am RNS Notice of AGM
19th Mar 2015 7:00 am RNS COLLABORATION WITH DAIICHI SANKYO INC
18th Mar 2015 7:04 am RNS POSITIVE PHASE III RESULTS FOR PT003 IN COPD
FTSE 100 Latest
Value8,837.91
Change26.87